yellow fever – APBN New Site

Novel Monoclonal Antibody Developed to Treat Yellow Fever

September 17, 2020 . Inside Industry

Singapore-based clinical-stage biotechnology company, Tychan announces results for Phase 1 Trial for TY014, a novel monoclonal antibody candidate treatment for yellow fever. Results of Phase 1 trial...

Highly Promising Antibody Treatment for Yellow Fever Formulated by SMART Researchers with Significant Reduction in Production Timeline

September 13, 2020 . Bioboard

A potential post-infection antibody treatment for yellow fever, named TY014, was devised by a multi-disciplinary research team at SMART. TY014 could complement vaccination efforts and reduce the risk...